InvestorsHub Logo
Followers 10
Posts 1562
Boards Moderated 0
Alias Born 09/14/2016

Re: fabius post# 32813

Thursday, 02/22/2018 6:36:15 PM

Thursday, February 22, 2018 6:36:15 PM

Post# of 38634
fabius........I agree that if we do not get a partnership and soon we go down much further. Then what? Many pharmas get taken over for a 30% premium. We go down to 50¢ then the take over price is 65¢ you think? The Odidis do not own enough of stock to stop it. That all sounds silly doesn't it. But many new shareholders will come on on the cheap and want a takeover for 30% profit, who wouldn't?

Some other thoughts.

I myself got suckered in to the verbiage:

Mr Patient and Mr Odidi’s words exactly during our shareholder meeting
“The shorts will pay very soon. They will lose”

Now I didn't post that or make that up, someone else did. And I was so ignorant to let that sit in my mind and give me a false hope that we had some super news in the next few weeks following that "special meeting".

A stock sells in the market for what it is worth. Risk is a major factor of course.

IPCI doesn't sign a new partnership ringing in big bucks it is OBVIOUS we have to dilute over and over.

No one from the company said why the WAY overdue generics still haven't been approved and there is no more backlog on generics. Other companies get their generics through in less than 1/2 the time we do. Are we that bad in the understanding of how to fill out the paperwork? Is it the lack of communication?

I do not see the Odidis taking a pay cut till we get profitable, do you?????

Okay get mad at me but waking up each day and seeing the market rallying and we go down another 5% is getting old.

Obviously no interest in their delivery system that is such a big secret.So much of a secret no one wants it.

Just a poorly run company, so much for plug & play the plug fell out of the socket a long time ago. If we ever do get the newly named opioid drug in the market it will be 2 to 3 more years and there are already something like 12 others out there that already are selling. Last one to the show, so much for the buzz words used over the past few years...BEST IN CLASS....FAST TRACKED....etc. Was on the train track to nowhere for everything was riding on Rexista whose name can not even be used.

And as I wind this up I still hope I am totally wrong ,but when the market value starts selling for less than what big pharma's throw away each week and no one wants to buy them you do have to raise a flag.